The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.00
Bid: 141.20
Ask: 142.80
Change: 1.00 (0.71%)
Spread: 1.60 (1.133%)
Open: 142.60
High: 145.00
Low: 142.00
Prev. Close: 141.00
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funds advised by Apax invest in Faculty

25 May 2021 07:00

RNS Number : 6429Z
Apax Global Alpha Limited
25 May 2021
 

Apax Global Alpha Limited

 

Funds advised by Apax announce investment in Faculty

 

On 24 May 2021, The Apax Digital Fund ("ADF"), in which AGA is a limited partner, announced an investment in Faculty, a leading British artificial intelligence ("AI") company. The investment is part of a £30m growth funding round led by ADF.

On a look through basis, AGA is expected to invest approximately €2.0m in the company. Note that these figures relate to AGA's look through position of the Apax Digital Fund's overall investment in Faculty and are stated before taking into account any closing adjustments and are translated into Euro based on today's exchange rates where applicable.1

Founded in 2014, Faculty has grown rapidly to become one of the world's most experienced teams of AI and machine learning specialists, able to support any organisation to make AI effective and drive value. The company has a specialist team that includes over 50+ PhDs with experience of working with over 200 customers across the globe.

The investment will help accelerate new product development, expand Faculty's geographic footprint, and drive the expansion of the company's 'AI as a Service' model. The investment will also support the rollout of Faculty's new learning and development programme, which will sit at the centre of the business to help develop technical and commercial talent as the company scales.

AGA, whose shares are listed on the London Stock Exchange, provides investors with access to a diversified portfolio of private equity funds advised by Apax as well as a focused portfolio of debt and equity investments ("Derived Investments"). In 2017, AGA made a commitment of $50m to ADF.

 

For more information about the transaction, please visit: https://www.apax.com/news/press-releases/

 

 

END

 

Contact details

Investor Relations - AGA

Katarina Sallerfors

T: +44 207 872 6526

E: Katarina.sallerfors@apax.com 

 

 

Footnotes

 

1.

Based on Bloomberg closing EUR/USD FX rate on 21 May 2021 of 1.2182

 

 

 

 

Notes

 

1.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax" or "the Investment Adviser"

 

2.

Please be advised that this announcement may contain inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014 ("MAR")

 

3.

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions

 

4.

The information presented herein is not an offer for sale within the United States of any equity shares or other securities of Apax Global Alpha Limited ("AGA"). AGA has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition, AGA's shares (the "Shares") have not been and will not be registered under the Securities Act or any other applicable law of the United States. Consequently, the Shares may not be offered or sold or otherwise transferred within the United States, or to, or for the account or benefit of, US Persons, except pursuant to an exemption from the registration requirements of the Securities Act and under circumstances which will not require AGA to register under the Investment Company Act. No public offering of the Shares is being made in the United States

 

5.

This announcement may include forward-looking statements. The words "expect", "anticipate", "intends", "plan", "estimate", "aim", "forecast", "project" and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding AGA's intentions, beliefs or current expectations concerning, among other things, AGA's results of operations, financial condition, liquidity, prospects, growth and strategies. The forward-looking statements in this presentation are based on numerous assumptions regarding AGA's present and future business strategies and the environment in which AGA will operate in the future. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of AGA to be materially different from those expressed or implied by such forward looking statements. Many of these risks and uncertainties relate to factors that are beyond AGA's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as AGA's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which AGA operates or in economic or technological trends or conditions. Past performance should not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. AGA expressly disclaims any obligation or undertaking to release any updates or revisions to these forward-looking statements to reflect any change in AGA's expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based after the date of this announcement, or to update or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on the forward-looking statements, which speak only as of the date of this announcement.

 

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

 

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in equities and debt derived from the insights gained via Apax's Private Equity activities.

 

Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

 

About Apax Partners LLP

 

Apax Partners LLP ("Apax") is a leading global private equity advisory firm. For nearly 50 years, Apax has worked to inspire growth and ideas that transform businesses. The firm has raised and advised funds with aggregate commitments of more than $60 billion. The Apax Funds invest in companies across four global sectors of Tech, Services, Healthcare and Internet/Consumer. These funds provide long-term equity financing to build and strengthen world-class companies. For more information see: www.apax.com.

 

Apax is authorised and regulated by the Financial Conduct Authority in the UK.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKSLAEXFEFA
Date   Source Headline
13th Jan 202311:10 amEQSHardman & Co Research on Apax Global Alpha (Initiation of coverage): Making pearls out of oysters
13th Jan 20237:00 amRNSDuck Creek Technologies to be acquired by Vista
10th Nov 20227:00 amRNSApax IX sells stake in Kepro
4th Nov 20227:00 amRNSQuarterly Results for 30 September 2022
22nd Sep 20227:00 amRNSApax IX agrees to sell stake in Authority Brands
14th Sep 20227:00 amRNSThe Apax Digital Fund II invests in Xeneta
19th Aug 20227:00 amRNS2022 Interim Dividend
19th Aug 20227:00 amRNS2022 Interim Report and Accounts
19th Aug 20227:00 amRNS2022 Interim Results Highlights
5th Aug 20227:00 amRNSApax Funds’ Valuations as at 30 June 2022
26th Jul 20227:00 amRNSFunds advised by Apax to acquire Pickles Auctions
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSProposed commitment to Apax XI
17th Jun 20227:00 amRNSDirector Declaration - Additional Directorship
10th Jun 20227:00 amRNSFunds Advised by Apax Sell Stake in MyCase
7th Jun 20227:00 amRNSFunds advised by Apax to acquire EcoOnline
13th May 20224:02 pmRNSDirector/PDMR Shareholding
12th May 20227:00 amRNSDirector/PDMR Shareholding
6th May 20227:00 amRNSResult of AGM
6th May 20227:00 amRNSIncrease to the Revolving Credit Facility
6th May 20227:00 amRNSQuarterly results for 31 March 2022
7th Apr 20227:00 amRNSProposed commitment to AMI Opportunities Fund II
22nd Mar 20227:00 amRNSApax Digital Funds invest in ClearBank
17th Mar 20223:59 pmRNSPurchase of Ordinary Shares under IM Agreement
8th Mar 20227:00 amRNSProposed commitment to Apax Global Impact Fund
2nd Mar 20227:00 amRNSKey Information Document
2nd Mar 20227:00 amRNS2021 Annual Dividend Declaration
2nd Mar 20227:00 amRNSNotice of AGM
2nd Mar 20227:00 amRNS2021 Annual Report and Accounts
2nd Mar 20227:00 amRNS2021 Final Results
14th Feb 20227:00 amRNSApax X invests in Alcumus and Ole Smoky
3rd Feb 20227:00 amRNSApax Funds’ Valuations as at 31 December 2021
31st Jan 20224:36 pmRNSPrice Monitoring Extension
23rd Dec 202110:30 amRNSDirector Declaration
17th Dec 20219:30 amRNSDirector Declaration
6th Dec 20217:00 amRNSFunds advised by Apax sell stakes in Unilabs
9th Nov 20217:00 amRNSInmarsat agrees combination with Viasat
4th Nov 20217:00 amRNSQuarterly results for 30 September 2021
2nd Nov 20217:00 amRNSFunds advised by Apax announce investment in Lever
1st Nov 20217:00 amRNSApax Funds to acquire HSG
6th Oct 20217:00 amRNSApax Funds to acquire Eating Recovery Center
16th Sep 20217:00 amRNSInitial Public Offering of Thoughtworks
8th Sep 20217:00 amRNSFunds advised by Apax to invest in T-Mobile
2nd Sep 20217:00 amRNSWizeline Acquired by CDPQ
1st Sep 20217:00 amRNSFunds advised by Apax to acquire SavATree
31st Aug 20215:40 pmRNSDirector/PDMR Shareholding
19th Aug 20217:00 amRNS2021 Interim Dividend
19th Aug 20217:00 amRNS2021 Interim Report and Accounts
19th Aug 20217:00 amRNS2021 Interim Results Highlights
5th Aug 20217:00 amRNSApax Funds’ Valuations as at 30 June 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.